Advertisement

Topics

Latest "Oncobiologics Announces Strategic Partnership With Tenshi Holdings Limited" News Stories

07:38 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Oncobiologics Announces Strategic Partnership With Tenshi Holdings Limited" found in our extensive news archives from over 250 global news sources.

More Information about Oncobiologics Announces Strategic Partnership With Tenshi Holdings Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Oncobiologics Announces Strategic Partnership With Tenshi Holdings Limited for you to read. Along with our medical data and news we also list Oncobiologics Announces Strategic Partnership With Tenshi Holdings Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of Oncobiologics Announces Strategic Partnership With Tenshi Holdings Limited Companies for you to search.

Showing "Oncobiologics Announces Strategic Partnership With Tenshi Holdings Limited" News Articles 1–25 of 13,000+

Saturday 16th February 2019

$AVEO Announces Oral Presentation of TIVO-3 Trial Topline Results at the ASCO #GU19 https://www.businesswire.com/news/home/20190216005008/en/AVEO-Oncology-Announces-Oral-Presentation-TIVO-3-Trial …

$AVEO Announces Oral Presentation of TIVO-3 Trial Topline Results at the ASCO #GU19 https://www.businesswire.com/news/home/20190216005008/en/AVEO-Oncology-Announces-Oral-Presentation-TIVO-3-Trial …


AVEO Oncology Announces Oral Presentation of TIVO-3 Trial Topline Results at the 2019 ASCO Genitourinary Cancers Symposium

AVEO Oncology (NASDAQ:AVEO) today announced the presentation of data from the Phase 3 TIVO-3 study of tivozanib (FOTIVDA®) versus sorafenib in refractory advanced or metastatic renal cell carcinoma (RCC). The data were presented by Brian Rini, MD, Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and Di...

COR Medspa Now Open, the Leading Aesthetic and Wellness Provider in Denville, NJ

DENVILLE, N.J. (PRWEB) February 15, 2019 State-of-the-art aesthetic and wellness provider, COR Medspa, announces its opening in Denville, NJ. Created by recognized physicians in urology, COR Medspa is committed to helping patients realize their best with the most effective aesthetic and sexua...


Friday 15th February 2019

MKSAP: 60-year-old woman with H. pylori gastritis

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 60-year-old woman is evaluated 1 month after completing a 14-day course of Helicobacter pylori eradication therapy consisting of amoxicillin, clarithromycin, and omeprazole. Initial upper endoscopy before treatment showed patchy gastric erythema with no ulcers or erosions, and biops...

Eradication of H. Pylori should be confirmed using the urea breath test or fecal antigen test

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 60-year-old woman is evaluated 1 month after completing a 14-day course of Helicobacter pylori eradication therapy consisting of amoxicillin, clarithromycin, and omeprazole. Initial upper endoscopy before treatment showed patchy gastric erythema with no ulcers or erosions, and biops...

TransCanna Announces Corporate Update Conference Call

Vancouver, British Columbia--(Newsfile Corp. - February 15, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") intends to host a corporate update conference cal...

$MRKR Announces Change in Corporate Headquarters and Access to New Laboratory Facility https://www.prnewswire.com/news-releases/marker-therapeutics-announces-change-in-corporate-headquarters-and-access-to-new-laboratory-facility-300796813.html …

$MRKR Announces Change in Corporate Headquarters and Access to New Laboratory Facility https://www.prnewswire.com/news-releases/marker-therapeutics-announces-change-in-corporate-headquarters-and-access-to-new-laboratory-facility-300796813.html …

SurgCenter Development Celebrates New Milestone with Formation of 200th ASC Partnership

SurgCenter Development, developer of ASCs and leader in outpatient total joint replacements, celebrates new milestone with formation of its 200th ASC, SurgCenter of Clearwater. TAMPA, Fla. (PRWEB) February 15, 2019 SurgCenter Development (http://www.surgcenter.com) (SCD), a leader in the development of ambulatory surgical centers (ASCs) throughout the U.S., celebrates the formation of its 200th A...

Kiadis Pharma Notice of Extraordinary General Meeting of Shareholders

                                                                  Amsterdam, The Netherlands, 15 February 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it has convened an extraor...

Vivacelle Bio, Inc. Receives FDA Clearance to Enroll Patients into its Phase IIa Clinical Trial of VBI-1 for Severe Blood Loss and/or Raising Blood Pressure in Hypovolemic Subjects

Vivacelle Bio, Inc. today announces that the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular support fluid that is designed for the treatment of patients with emergently life-threate...

Cambrooke Therapeutics and Trovita Health Science Announce Strategic Alliance for ENU® Nutrition

Cambrooke Therapeutics, a member of The Ajinomoto Group, and Trovita Health Science, a specialty medical nutrition company, announce a joint marketing

The Biotech Growth Trust (BIOG) - Industry backdrop remains favourable

Edison Investment Research - Investment trusts - The Biotech Growth Trust: The Biotech Growth Trust (BIOG) is managed by Geoff Hsu and Richard Klemm at OrbiMed Capital, one of the leading global healthcare asset managers. The year 2018 proved to be tough for the trust’s performance as biotech companies delivering negative news were heavily penalised, while those delivering good news went unr...

Deutsche Beteiligungs (DBAN) - Market sentiment weighing on portfolio value

Edison Investment Research - Investment trusts - Deutsche Beteiligungs: Deutsche Beteiligungs (DBAG) is making steady progress on its investment agenda, with three new acquisitions and several follow-on funding rounds totalling €40.2m completed in Q119. DBAG’s Fund VII has so far been able to allocate 56% of its investment commitments in seven transactions, reflecting solid portfolio r...

WANdisco (158355634WAND) - Increasing importance in the cloud ecosystem

Edison Investment Research - Technology - WANdisco: WANdisco’s designation as an Amazon Web Services (AWS) Advanced Technology Partner strengthens its position in the cloud ecosystem. We believe that a large, strategic deal remains in the pipeline, and the $17.5m capital raising (at a premium), should reassure potential partners. Our estimates are adjusted to reflect the new shares, but are ...

Griffin Health launches its frameless SRS program using C-RAD Catalyst HD with cBrain software

Griffin Health launches its frameless SRS program using C-RAD Catalyst HD with cBrain software C-RAD announced today that the Center for Cancer Care at Griffin Hospital in Derby, CT, in partnership with physicians and physicists from the Yale University School … Continue reading →

Hoth Therapeutics Announces Pricing of Initial Public Offering and Trading on the Nasdaq

Hoth Therapeutics (NASDAQ:HOTH) has announced the pricing of its initial public offering of 1,250,000 shares of its common stock at an initial offering price to the public of $5.60 per share. As quoted in the press release:  All shares of common stock are being offered by Hoth. In addition, Hoth has granted the underwriters a 30-day option … Continued The post Hoth Therapeutics Announces ...

Ross University School of Medicine & Florida Agricultural and Mechanical University Partner to Increase Physician Diversity in the U.S.

Schools create pathway program for graduates of the HBCU to attend medical school African Americans make up only six percent1 of U.S. physicians. With the goal of driving diversity among U.S. physicians, today Florida Agricultural and Mechanical University (FAMU) and Ross University School of Medicine (RUSM) announced a new agreement to help more Afric...

Cyient Recognized as a "Major Contender" in Everest Group's PEAK Matrix(TM): Medical Device Engineering Services Assessment 2019

~The recognition further strengthens Cyient's position as a leading global medical technology and healthcare solutions provider HYDERABAD, India, Feb. 15, 2019 /PRNewswire/ -- Cyient, a global provider of engineering, manufacturing, geospatial, networks, digital, and operations management solutions to global industry leaders, has been p...

CORRECTING and REPLACING Zebra Medical Vision is Granted Three Israeli Government Grants to Deploy Medical Imaging AI at Scale

Zebra Medical Vision announces it’s the recipient of three grants from the Israeli innovation authority to provide AI analysis at Ichilov Hospital, and through Integrated health providers Maccabi and Clalit. Seventh paragraph of release dated February 14, 2019, quote should read: "... to advance the health of its members. Clalit is working ...

HOOKIPA Appoints Michael A. Kelly as Independent Director.

New York, US and Vienna, Austria – 15 February 2019 – HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the appointment of Michael A. Kelly to the Company’s Board of Directors. Mr. Kelly is a former senior exe...

Rallye bei Aphria: Aktie gewinnt mehr 7%: Sonderausschuss mit positivem Resultat - auch Aurora und Canopy deutlich im Plus

Nun ist er da: Der Bericht des unabhängigen Sonderausschusses, den Aphria beauftragt hat, um die gegen das Unternehmen erhobenen Vorwürfe im Zusammenhang mit der Übernahme von LATAM Holdings zu unt...

Secret announces new products, campaign casting call

Secret announced the launch of four new product

FDA Announces Breakthrough Therapy Designation to CymaBay’s Seladelpar for Treatment of Primary Biliary Cholangitis

NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for seladelpar for the treatment of early stage primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adult patients with an inadequate response to UDCA, …

Triple Ring Technologies Executive Wins International Innovation Award

Triple Ring Technologies, a leading research and development firm that partners with its clients to develop innovative products and to launch new businesses, announces today that their Vice President of Projects, Christina Sejr Pedersen, recently

HOOKIPA Appoints Michael A. Kelly as Independent Director

HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the appointment of Michael A. Kelly to the Company’s Board of Directors. Mr. Kelly is a former senior executive of Amgen, Inc. currently acting as Foun...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks